FIELD: medicine, chemotherapy.
SUBSTANCE: the present innovation deals with intrathecal introduction of metotrexate at the quantity of 1.2-2.5 mg/kg patient's body weight along with cytozar at the quantity of 3-5 mg/kg and hydrocortisone at the quantity of 125 mg at preliminary cerebral dehydration and intravenous introduction of cerebrolysine. Since the second day of chemopreparations introduction it is necessary to conduct 1-2 plasmapheresis seances. Preparations should be introduced thrice at 7-d-long intervals, further - once monthly, thrice. The method decreases toxic complications of chemotherapy performed.
EFFECT: higher efficiency of therapy.
2 cl, 1 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
CHEMOTHERAPY METHOD FOR TREATING MALIGNANT TUMORS OF THE CENTRAL NERVOUS SYSTEM | 2005 |
|
RU2290202C1 |
METHOD FOR DELIVERING NANOPARTICLES INTENDED FOR THE TRANSPORT OF DRUGS TO THE BRAIN OF MAMMALS THROUGH THE BLOOD-BRAIN BARRIER | 2017 |
|
RU2670091C1 |
METHOD FOR FINDING INDIVIDUAL THERAPY FOR TREATING PATIENTS FOR INTRACEREBRAL MALIGNANT TUMORS | 2004 |
|
RU2273474C1 |
THERAPY OF BONE METASTASES IN BREAST CANCER | 2007 |
|
RU2360682C1 |
METHOD OF TREATING SPINE TUMOURS | 2014 |
|
RU2551622C1 |
METHOD FOR TREATMENT OF MULTIPLE MYELOMA WITH INTRASPINAL TUMOR GROWTH | 2001 |
|
RU2213563C2 |
METHOD OF PALLIATIVE TREATMENT OF EXTENDED PROSTATE CANCER WITH METASTATIC BACKBONE DAMAGE | 2002 |
|
RU2238082C2 |
METHOD FOR TREATING ONCOLOGICAL PATIENTS WITH METASTATIC CEREBRAL LESION | 2005 |
|
RU2290974C1 |
METHOD FOR CHEMORADIATION THERAPY OF BRAIN MALIGNANT GLIAL TUMOR | 2005 |
|
RU2296567C1 |
METHOD FOR CHEMORADIATION THERAPY OF MALIGNANT CEREBRAL MENINGIOMAS | 2005 |
|
RU2294740C1 |
Authors
Dates
2004-10-27—Published
2000-04-14—Filed